Give regimen of abdomenal tb

Reading File
Finding Sources
Finding Sources
Searching PubMed

"abdominal tuberculosis" AND treatment

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive information to provide a detailed, textbook-referenced answer. Let me compile the complete regimen.

Abdominal Tuberculosis - Treatment Regimen

Abdominal TB (including intestinal TB, peritoneal TB, and TB lymphadenitis in the abdomen) is treated with the same standard anti-tubercular chemotherapy used for pulmonary TB. It is classified as extrapulmonary TB.

Standard Drug-Susceptible Regimen (First-Line)

PhaseDurationDrugsNotation
Intensive phase2 monthsIsoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E)2HRZE
Continuation phase4 monthsIsoniazid (H) + Rifampicin (R)4HR
Total duration6 months2HRZE / 4HR
"The preferred regimen for treating adults with TB caused by organisms not known or suspected to be drug resistant consists of an intensive phase of 2 months of INH, RIF, PZA, and ethambutol (EMB), followed by a continuation phase of 4 months of INH and RIF." - Murray & Nadel's Textbook of Respiratory Medicine

Drug Doses (Adult, Weight-Based)

DrugDaily DoseMaximum
Isoniazid (H)5 mg/kg300 mg/day
Rifampicin (R)10 mg/kg600 mg/day
Pyrazinamide (Z)25 mg/kg2000 mg/day
Ethambutol (E)15 mg/kg1600 mg/day
Daily dosing (7 days/week) is preferred in both phases per ATS/CDC/IDSA guidelines. Even minimal non-adherence significantly increases the risk of poor outcomes.

When to Extend Duration

  • 9 months total (2HRZE + 7HR): If there is cavitation on initial imaging AND positive culture at 2 months - both factors together suggest higher relapse risk.
  • Consider extension in severely malnourished patients or those with delayed clinical response.
  • Note: "Most forms of extrapulmonary TB in children can be treated with the same regimens as used in adults." - Murray & Nadel's

Adjunctive Corticosteroids

Corticosteroids (prednisolone) may be added as adjuncts in specific scenarios:
  • Peritoneal TB: To reduce the risk of adhesions and stricture formation
  • Ascites from TB: To hasten fluid reabsorption
  • Intestinal TB (post-medical treatment): To decrease stricture formation and bowel obstruction risk
"Corticosteroids can be considered for children with... abdominal TB (to decrease the risk of strictures)." - Red Book 2021
Typical dose: Prednisolone 1-2 mg/kg/day, tapered over 6-8 weeks.

Surgical Indications (Adjunct to Medical Therapy)

Surgery is NOT first-line but may be needed for:
  • Intestinal obstruction from strictures - strictureplasty or limited ileocolic resection
  • Bowel perforation with peritonitis - resection + ileostomy (anastomosis avoided in active infection)
  • Diagnostic laparoscopy when diagnosis is uncertain
  • After medical treatment: re-image the small bowel; persistent/significant strictures need elective resection
Post-operatively, patients should receive the full standard 6-month ATT course under combined physician-surgeon care. - Bailey & Love's Short Practice of Surgery, 28th Ed.

Directly Observed Therapy (DOT)

DOT is recommended by ATS/CDC/IDSA - a case manager supervises each dose. Studies show >90% adherence is needed; even slight non-adherence increases relapse risk (HR 2.4 to 5.9 for poor outcomes).

Drug Resistance Considerations

  • If drug-susceptible (INH + RIF sensitive confirmed): EMB can be dropped after susceptibility confirmed, and intensive phase uses only 3 drugs (HRZ).
  • MDR-TB or XDR-TB requires specialist referral and completely different regimens.
  • Never add a single drug to a failing regimen - always add 2-3 drugs to avoid amplification of resistance.

Monitoring During Treatment

MonitoringFrequency
Liver function tests (ALT)Baseline; monthly or if symptomatic
Serum creatinineBaseline
Visual acuity + color discrimination (Ethambutol)Baseline, then monthly
WeightMonthly (dose-adjust if significant change)
HIV testingAll patients at baseline
Symptom review (nausea, jaundice, rash)Each visit
Stop hepatotoxic drugs (INH, RIF, PZA) if ALT >5x ULN (asymptomatic) or >3x ULN with symptoms.

Sources: Murray & Nadel's Textbook of Respiratory Medicine (2-Volume) | Bailey & Love's Short Practice of Surgery, 28th Ed. | Red Book 2021 | Jawetz Melnick & Adelberg's Medical Microbiology 28E

What are the typical complications and their management during ATT for abdominal TB?

Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
I now have thorough textbook data to compose a complete, well-organized answer.

Complications During ATT for Abdominal TB and Their Management

Complications fall into two broad groups: (A) Drug-related adverse effects from ATT itself, and (B) Disease-related complications from the TB infection during or after treatment.

A. Drug-Related Complications

1. Hepatotoxicity (Most Common Serious Adverse Effect)

Causative drugs: INH > PZA > RIF (all three can cause liver injury)
SituationAction
Asymptomatic ALT rise (mild)Continue ATT; increase monitoring frequency
ALT >5x ULN (any symptoms) OR >3x ULN with symptomsStop all hepatotoxic drugs immediately
Bilirubin + ALP disproportionately highSuspect RIF-specific hepatotoxicity
"Drug-induced hepatitis is the most frequent serious adverse reaction to first-line drugs. An asymptomatic increase in ALT may be observed in nearly 20% of patients..." - Murray & Nadel's Respiratory Medicine
Management steps:
  1. Stop ATT; rule out other causes (viral hepatitis, alcohol, biliary disease)
  2. If patient is seriously ill/infectious: start a liver-sparing bridge regimen: Ethambutol + Levofloxacin + Aminoglycoside (streptomycin/amikacin)
  3. Monitor ALT until it falls to <2x ULN, then restart sequentially:
    • RIF first (least hepatotoxic) ± EMB → wait 3-7 days
    • Then restart INH
    • If ALT remains stable: restart PZA (most hepatotoxic - omit if prior severe reaction)
  4. If PZA cannot be restarted: extend total ATT duration to 9 months (2HRE + 7HR)
Risk factors for ATT hepatotoxicity: Age >60, female sex, HIV, chronic liver disease (hepatitis B/C), alcohol use, Asian ethnicity, slow NAT2 acetylator genotype.

2. Peripheral Neuropathy (INH)

Mechanism: INH competitively inhibits pyridoxine (Vitamin B6), causing functional B6 deficiency
Incidence: ~2% at standard doses (5 mg/kg/day); rises to >17% at higher doses
High-risk groups: Diabetics, HIV patients, malnourished patients, alcoholics, CKD, elderly, pregnant/breastfeeding women
Management:
  • Prevention (mandatory in high-risk): Pyridoxine 25-50 mg/day with each INH dose
  • Some experts give pyridoxine to ALL patients on INH
  • If neuropathy develops despite pyridoxine: increase dose to 100 mg/day
  • If refractory: consider dose reduction or cessation of INH
Seizures from INH toxicity (rare, usually overdose):
  • Hospitalize immediately
  • IV pyridoxine (gram-for-gram if INH dose unknown) + antiepileptics (benzodiazepines)

3. Optic Neuritis (Ethambutol)

Presentation: Reduced visual acuity, central scotoma, loss of green-red color discrimination
Incidence: ~19/1000 patients at doses ≤27.5 mg/kg/day; dose-dependent
Management:
  • Baseline visual acuity (Snellen) + color discrimination before starting EMB; repeat monthly
  • Stop EMB immediately if any visual symptoms develop
  • Refer to ophthalmologist promptly
  • Recovery takes ~3 months on average but can be permanent if delayed
  • Children too young to report visual changes: weigh risk-benefit carefully

4. Hyperuricemia and Gout (Pyrazinamide)

Mechanism: PZA inhibits renal uric acid excretion
Management:
  • Asymptomatic hyperuricemia: No treatment needed; monitor
  • Symptomatic gout: Allopurinol (xanthine oxidase inhibitor) or other urate-lowering therapy
  • Avoid aspirin (interferes with uric acid handling); use NSAIDs with caution
  • PZA is contraindicated in acute gout
  • Note: Ethambutol can also cause mild hyperuricemia

5. GI Symptoms (Nausea, Vomiting, Abdominal Pain)

Causative drugs: All first-line drugs, especially PZA and EMB
- Important: First rule out hepatotoxicity by checking ALT/bilirubin before attributing to simple GI intolerance
Management:
  • Take medications at bedtime to minimize symptoms
  • Take with a light low-fat snack
  • Antacids or proton pump inhibitors (PPIs)
  • Antiemetics 30 min before ATT: ondansetron, metoclopramide, or promethazine

6. Skin Rash / Hypersensitivity

All four first-line drugs can cause rashes.
Rash typeDrugManagement
Simple pruritic rash, no systemic signsAnyAntihistamines ± topical corticosteroids; continue ATT
PhotosensitivityPZAAvoid sun, use sunscreen; can persist weeks after stopping PZA
Petechial rash / thrombocytopeniaRIFStop RIF; replace with rifabutin once platelets recover
Mucous membrane involvement / feverAnySuspect Stevens-Johnson syndrome - stop all ATT; dermatology + TB specialist consult
Rash + eosinophilia + lymphadenitis + organ involvementAnySuspect DRESS syndrome - stop all ATT immediately; specialist consult
Reintroduction after rash: Restart drugs sequentially at 2-3 day intervals; if rash recurs, stop the last drug added.

7. Rifampicin-Specific: Important Drug Interactions

RIF is a potent inducer of CYP450 enzymes - a critical concern in abdominal TB patients on other drugs:
  • Oral contraceptives: Reduced efficacy - advise barrier contraception
  • Antiretrovirals (HIV co-infection): Major interaction with protease inhibitors/NNRTIs - use rifabutin instead, or specialist-guided regimen
  • Warfarin: Reduced anticoagulant effect - monitor INR closely, dose-adjust
  • Corticosteroids: Reduced steroid effect - may need to increase steroid dose (relevant when using adjunctive steroids for peritoneal TB)
  • Orange discoloration of urine, tears, saliva, skin - warn patients; harmless but distressing

B. Disease-Related Complications (During/After ATT)

8. Intestinal Obstruction from Strictures

This is the most important disease complication specific to abdominal TB. Strictures can:
  • Pre-exist before ATT begins
  • Paradoxically develop or worsen in the first 2-3 months after starting ATT (due to fibrosis during healing)
Management (elective):
  • After completing medical treatment, re-image the small bowel (barium follow-through or CT enterography)
  • Persistent symptomatic strictures → surgical options:
    • Strictureplasty (single short stricture)
    • Limited ileocolic resection + anastomosis (ileocaecal hyperplastic disease)
    • Right hemicolectomy (extensive ileocolic disease)
    • "Surgical principles are similar to Crohn's disease - resections should be kept as conservative as possible." - Bailey & Love's Surgery, 28th Ed.
Management (emergency - acute obstruction):
  1. Vigorous IV resuscitation (correct dehydration, electrolytes, anemia)
  2. Laparotomy: minimum life-saving procedure
    • Resection of obstructed segment + proximal ileostomy + distal mucus fistula (anastomosis avoided in acute infection - high leak risk)
    • Primary anastomosis only if the patient's general condition permits
  3. Continue full 6-month ATT course post-operatively under combined physician-surgical care

9. Bowel Perforation

  • Rare; from a perforated tuberculous ulcer in the small bowel
  • Presents as acute peritonitis
  • Requires emergency laparotomy, resection, and peritoneal lavage
  • ATT continued post-operatively

10. Paradoxical Reactions (Immune Reconstitution)

Definition: Temporary clinical or radiographic worsening despite appropriate ATT and good adherence - due to restored immune response attacking TB antigens
In abdominal TB: May manifest as:
  • Worsening abdominal pain or ascites
  • Enlarging mesenteric lymph nodes
  • New or worsening bowel obstruction symptoms
In HIV co-infected patients on ART: Known as Immune Reconstitution Inflammatory Syndrome (IRIS) - presents with fever, lymphadenopathy, expanding lesions
Management:
  • Rule out treatment failure and drug resistance first
  • Continue ATT (do NOT stop)
  • Corticosteroids (prednisolone 1-2 mg/kg/day) for severe paradoxical reactions, tapered over 4-8 weeks
  • For IRIS: continue both ATT and ART; add steroids for severe cases

Summary Table

ComplicationCausative DrugKey Management
HepatotoxicityINH, PZA, RIFStop if ALT >5x ULN; restart sequentially (RIF → INH → PZA)
Peripheral neuropathyINHPyridoxine 25-50 mg/day (prevent); 100 mg/day (treat)
Optic neuritisEMBMonthly visual monitoring; stop EMB immediately if symptoms
Hyperuricemia/goutPZAAllopurinol for symptomatic gout; monitor uric acid
GI intoleranceAll (esp. PZA)Bedtime dosing, light snack, PPIs, antiemetics
Rash/hypersensitivityAllAntihistamines (mild); stop all ATT (SJS/DRESS)
CYP450 drug interactionsRIFAdjust warfarin, OCP, ART doses accordingly
Intestinal obstructionDisease (stricture)Strictureplasty / resection (elective); ileostomy (emergency)
Paradoxical reactionImmune responseContinue ATT; add steroids for severe cases
PerforationDiseaseEmergency surgery + continue ATT
Sources: Murray & Nadel's Textbook of Respiratory Medicine | Bailey & Love's Short Practice of Surgery, 28th Ed. | Katzung's Basic & Clinical Pharmacology, 16th Ed. | Lippincott Illustrated Reviews: Pharmacology | Harrison's Principles of Internal Medicine, 22nd Ed.
This is a shared conversation. Sign in to Orris to start your own chat.